<p>Skin aging involves complex molecular changes that current strategies struggle to reverse. Here, we developed a machine learning approach using Support Vector Regression to predict biological skin age from proteomic profiles, enabling objective assessment of anti-aging formulations. In this exploratory, proof-of-concept, prospective observational study, we set out to characterize treatment-induced proteomic changes in human skin as the pre-specified primary outcome. Women (ages 20–80) received 30-day topical quinoa bioester application on one forearm, with the contralateral forearm receiving vehicle. Mass spectrometry revealed significant upregulation of barrier function proteins (desmoglein-1, filaggrin), antioxidant enzymes (SOD1, glutaredoxin-1), and protease inhibitors. Our Support Vector Regression (SVR) model, trained on pre-treatment proteomes, predicted lower proteomic ages for quinoa bioester-treated skin compared to vehicle-treated skin, with observed median differences of 11 and 16 years for participants under and over 50, respectively (p &lt; 0.01 for participants ≥50 years). While these values do not necessarily correspond to biological years, these findings demonstrate that topical bioactives can induce detectable shifts in skin proteomic profiles. These results establish a quantitative framework for evaluating skin rejuvenation strategies and suggest quinoa bioester as a promising anti-aging cosmeceutical.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Quinoa bioester application shifts human skin proteome toward molecular profiles associated with younger age

  • Amanda C. Camillo-Andrade,
  • Lucas A. Sales,
  • Carolina M. Catarino,
  • Bruna Bosquetti,
  • Camila F. S. Oliveira,
  • Patricia H. Szuchman,
  • Andrezza D. P. M. Canavez,
  • Ana Raquel I. Firmino,
  • Rodrigo C. Romanhole,
  • Gustavo Dieamant,
  • Desiree C. Shuck,
  • Rosario Duran,
  • Juliana S. G. Fischer,
  • Marlon D. M. Santos,
  • Paulo C. Carvalho

摘要

Skin aging involves complex molecular changes that current strategies struggle to reverse. Here, we developed a machine learning approach using Support Vector Regression to predict biological skin age from proteomic profiles, enabling objective assessment of anti-aging formulations. In this exploratory, proof-of-concept, prospective observational study, we set out to characterize treatment-induced proteomic changes in human skin as the pre-specified primary outcome. Women (ages 20–80) received 30-day topical quinoa bioester application on one forearm, with the contralateral forearm receiving vehicle. Mass spectrometry revealed significant upregulation of barrier function proteins (desmoglein-1, filaggrin), antioxidant enzymes (SOD1, glutaredoxin-1), and protease inhibitors. Our Support Vector Regression (SVR) model, trained on pre-treatment proteomes, predicted lower proteomic ages for quinoa bioester-treated skin compared to vehicle-treated skin, with observed median differences of 11 and 16 years for participants under and over 50, respectively (p < 0.01 for participants ≥50 years). While these values do not necessarily correspond to biological years, these findings demonstrate that topical bioactives can induce detectable shifts in skin proteomic profiles. These results establish a quantitative framework for evaluating skin rejuvenation strategies and suggest quinoa bioester as a promising anti-aging cosmeceutical.